Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

the end of the trial to assess heart valve function over time. In contrast to the BLOOM trial, there were no echocardiographic exclusion criteria for entry into BLOSSOM and there was no oversight or interim data review monitoring by an independent safety monitoring board.

Phase 3 Program Overview

The lorcaserin Phase 3 program consists of three trials: BLOOM, BLOSSOM and BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus). Enrollment in the lorcaserin Phase 3 program is complete with approximately 7,800 patients. Positive results from BLOOM were presented at the 69th Scientific Sessions of the American Diabetes Association in June 2009. BLOOM and BLOSSOM comprise the Phase 3 pivotal registration program and will be the basis for the lorcaserin NDA submission. BLOOM-DM, which is planned as a supplement to the NDA, is evaluating 10 mg of lorcaserin dosed once or twice daily versus placebo over a one-year treatment period in obese and overweight patients with type 2 diabetes at about 60 sites in the US.

A standardized program of moderate diet and exercise guidance is included in the Phase 3 program. The program's hierarchically ordered co-primary efficacy endpoints are: the proportion of patients achieving 5% or greater weight loss after 12 months, the difference in mean weight loss compared to placebo after 12 months, and the proportion of patients achieving 10% or greater weight loss after 12 months. Arena is also studying several key secondary endpoints, including changes in serum lipids, markers of inflammation and insulin resistance, and in the BLOOM-DM trial, other indicators of glycemic control.

About the FDA Draft Guidance

The FDA draft guidance document "Developing Products for Weight Management" dated February 2007 provides recommendations regarding the development of drugs for t
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. (Nasdaq: ... $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is ... has completed a successful Phase 2 program in patients with ...
... , , , STOCKHOLM, December ... raising 380 MSEK (approximately 36,MEUR). This will secure Karolinska Development,s ... "The significant interest in this share issue shows ... us to pursue our long term,investment strategy. I am also ...
Cached Medicine Technology:Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR) 2
(Date:6/30/2015)... ... 30, 2015 , ... New Xarelto lawsuit claims proposed for ... new forms, according to attorneys handling Xarelto lawsuits included in the ... “provide guidance” for plaintiffs’ attorneys in filing new claims, according to court documents. ...
(Date:6/30/2015)... ... June 30, 2015 , ... AvePoint, the established ... of three new apps – AvePoint Watermark, AvePoint MyWorld, and ... of these apps, workers can better streamline everyday business operations and take advantage of ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American ... 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will ... this premiere event for psychiatric-mental health nursing draws more than 1,500 health care ...
(Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, ... the Peacock Alley story including hard work, tenacity, perseverance, commitment to quality, honesty and ... , Born of Mary Ella Gabler's simple love of quilts, Peacock Alley was ...
(Date:6/29/2015)... ... June 30, 2015 , ... Sublime Beauty NATURALS® introduces its ... The oil, ideal for natural skincare and even culinary uses, was especially designed ... something most people desire, and Oil Pulling can accomplish this. Oil Pulling is an ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... Hillenbrand,Industries, Inc. (NYSE: HB ) today announced ... share. This dividend was declared by Hillenbrand,s,Board of ... to shareholders of,record as of September 14, 2007. ... is organized into two operating companies,serving the health ...
... Fair Election Agreement Would Establish Rules for Union Process, ... Medical Centers delivered a message to CEO Tim Joslin ... hospital,facilities are putting the quality of treatment offered there ... negotiate a free and fair election,agreement with employees who ...
... where small changes make a huge impact, PHILADELPHIA, ... we celebrate the end of Healthy Steps, a six-week ... Housing,Authority, and Philadelphia Safe and Sound on Friday, September ... Center, 2500 Jackson Street in,South Philadelphia., The Urban ...
... million from the Centers for Disease Control and Prevention ... HIV/AIDS in eight countries that lack the large-scale public ... million of the grant will support the efforts of ... Health of Ethiopia and rural Jimma University, to ...
... CHAPEL HILL, N.C., Sept. 7 Pharmaceutical companies,face ... product research,sales and marketing forces, and quality production ... the industry. The case studies in the,Multi-Year Compendium ... more. They were presented by industry leaders at ...
... Sept. 7 With safety issues making,headlines, ... rugged,regulatory landscape. Organizations are relying on their ... affect production. Proper,staffing of quality roles is ... and a study by pharmaceutical benchmarking leader ...
Cached Medicine News:Health News:Hospital Workers: Management Threatens Patient Care 2Health News:On September 7th Local Organizations Partner to Celebrate 'Healthy Steps' 2Health News:Tulane University to receive $14M for international HIV/AIDS program 2Health News:Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC 2Health News:Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance 2
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 8-multi channels...
... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
Medicine Products: